Tag Archives: Biogen (Cambridge Massachusetts)

Estimating the Global Economic Impact of Dementia (BMJ Open / ROADMAP Group)

Posted on January 29, 2018 by Dementia and Elderly Care News

Summary Further work is underway to determine the costs and resource utilisation arising from dementia of all types. The total estimation will cover the personal and societal costs incurred by patients, their families and carers, and by national and local … Continue reading →

Posted in Acute Hospitals, Charitable Bodies, Commissioning, Community Care, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Management of Condition, Models of Dementia Care, Nuffield Trust, Person-Centred Care, Personalisation, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Alzheimer Centre Limburg (Maastricht), Attributable Cost of Dementia, Biogen (Cambridge Massachusetts), BMJ Open, BMJ Publishing Group Ltd, Bodleian Health Care Libraries: University of Oxford, Burden of Dementia, Burden of Dementia (Statistics), Burden on Caregivers, Carer Burden in Dementia, Cost Drivers in Dementia, Cost of Dementia to Business, Counting the Cost, Department of Neurobiology Care Science and Society: Karolinska Institute, Department of Psychiatry and Neuropsychology: Maastricht University, Division of Neurogeriatrics: Karolinska Institute, Economic Impact of Dementia, Effective Public Health Practice Project (Quality Assessment Tool), Eli Lilly and Company, Family Caregivers, Financial Cost of Dementia, Financial Modelling, GE Healthcare Life Sciences (Amersham UK), Global Burden of Dementia, Global Head Health Economic Modelling and Methodology: Novartis Pharmaceutical AG, Global Impact of Dementia, Global Impact of Dementia: World Alzheimer Report 2015, Global Societal Economic Cost of Dementia, Health Economics Research Centre: University of Oxford, Hidden Costs of Dementia, Impact of Dementia (Statistics), Impact of Dementia on Care Services, Karolinska Institute, London School of Economics and Political Science, Maastricht University, Netherlands, Novartis Pharmaceutical AG (Basel), Nuffield Department of Population Health: University of Oxford, Oxford, Personal Social Services Research Unit: London School of Economics and Political Science, Real World Outcomes Across the Alzheimer's Disease Spectrum for Better Care: Multi-Modal Data Access Platform (ROADMAP), ROADMAP Group, School for Mental Health and Neurosciences: Alzheimer Centre Limburg, Social and Economic Impact of Dementia, Societal Costs of Dementia, Sweden, Switzerland, Systematic Literature Reviews, Systematic Reviews and Meta-Analyses, University of Oxford, Unpaid Caregivers (Carers), USA, Value and Access: Biogen, World Alzheimer Report 2015, Worldwide Costs of Dementia | Leave a comment

Tag Archives: Biogen (Cambridge Massachusetts)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites